AOK NIEDERSACHSEN DIE GESUNDHEITSKASSE
A United Kingdom buyer, with 3 published contracts, most recently 8 months ago.
This contract opportunity involves establishing a non-exclusive discount agreement for medications containing the active ingredient Teriparatide (ATC Code: H05AA02). The contract will be effective from December 1, 2025, to November 30, 2027, with the option for suppliers to enter into the contract a
This contract opportunity involves establishing a non-exclusive discount agreement for the medication Omalizumab (ATC Code: R03DX05) in Germany. The contract will be effective from December 1, 2024, to November 30, 2026, with the option for suppliers to enter into the contract at any time during thi
This contract opportunity involves the establishment of non-exclusive discount agreements for the drug Trastuzumab, classified under ATC code L01FD01, in the regions of Lower Saxony, Bremen, and Saxony-Anhalt. The focus is on parenteral preparations made from finished medicinal products for oncology
